Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries.

NCT05246410 is registered in ClinicalTrials.gov with Acotec Scientific Co., Ltd as lead sponsor.

NCT NCT05246410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05246410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries.
Lead sponsor
Acotec Scientific Co., Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
August 17, 2022
Completion date
December 30, 2024
Enrollment
196 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease (pad), peripheral vascular disease (pvd)